Wed. 14 Feb 2024, 4:25pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. The company reported quarterly sales of $45.78 million which missed the analyst consensus estimate of $48.46 million by 5.52 percent. This is a 17.05 percent decrease over sales of $55.20 million the same period last year.